Markets
Is Second Sight Medical Products Inc. (NASDAQ:EYES) Still Worth A Bite?
Second Sight Medical Products Inc. (NASDAQ:EYES) previous close was $7.00 while the outstanding shares total 23.54M. The firm has a beta of 3.41. EYES’s shares
Second Sight Medical Products Inc. (NASDAQ:EYES) previous close was $7.00 while the outstanding shares total 23.54M. The firm has a beta of 3.41. EYES’s shares
Second Sight Medical Products Inc. (NASDAQ:EYES) previous close was $6.28 while the outstanding shares total 23.54M. The firm has a beta of 3.42. EYES’s shares
Second Sight Medical Products Inc. (NASDAQ:EYES) has a beta of 3.43. The stock’s Relative Strength Index (RSI) is 61.02, with weekly volatility at 15.86% and
Second Sight Medical Products Inc. (NASDAQ:EYES) Relative Strength Index (RSI) is 44.70, with weekly volatility at 10.07% and ATR at 0.62. The EYES stock’s 52-week
Second Sight Medical Products Inc. (NASDAQ:EYES) Relative Strength Index (RSI) is 37.10, with weekly volatility at 9.96% and ATR at 0.69. The EYES stock’s 52-week
Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.
All rights reserved © 2024, Powered by Smart TechOne